Phase I clinical trial of nasopharyngeal radiotherapy and concurrent celecoxib for patients with locoregionally advanced nasopharyngeal carcinoma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Oral Surgery
Reference33 articles.
1. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China;Jia;BMC Cancer,2006
2. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials;Chua;J Clin Oncol,2005
3. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong nasopharyngeal cancer study group;Lee;J Clin Oncol,2005
4. COX-2 as a target for cancer chemotherapy;Ghosh;Pharmacol Rep,2010
5. Cyclooxygenase-2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications;Tan;J Clin Pathol,2005
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis;Frontiers in Immunology;2023-03-23
2. The Efficacy of Celecoxib During Chemoradiation in Locally Advanced Head and Neck Carcinoma; A Phase 2 Randomized Placebo-Controlled Clinical Trial;International Journal of Cancer Management;2021-06-12
3. Celecoxib enhances the sensitivity of non-small-cell lung cancer cells to radiation-induced apoptosis through downregulation of the Akt/mTOR signaling pathway and COX-2 expression;PLOS ONE;2019-10-15
4. Celecoxib suppresses lipopolysaccharide‑stimulated oral squamous cell carcinoma proliferation in�vitro and in�vivo;Oncology Letters;2019-10-10
5. Celecoxib mitigates genotoxicity induced by ionizing radiation in human blood lymphocytes;Research in Pharmaceutical Sciences;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3